Insights

We spoke with Ted Schutzbank, PhD D(ABMM), Scientific Affairs Manager of Diagnostics at Meridian Bioscience about the importance of standardization in molecular diagnostics and the new testing methods available for COVID-19.

Written By Sherry A. Dunbar, PhD, MBA, Senior Director, Global Scientific Affairs, Luminex Corporation and Shubhagata Das, Scientific Affairs Manager, Luminex Corporation As of April 8, 2020, the...

Performing a Biological Risk Assessment in the Laboratory

Taking blood samples from children can be difficult for the phlebotomist. Ensuring safety while accounting for a pediatric patient’s emotional and physical well-being is of the utmost importance.

Measurement procedure comparison is one of the most common techniques used by both manufacturers and medical laboratorians to estimate the bias of an in vitro diagnostic (IVD) measurement procedure relative to a comparator.

At the invitation of US Centers for Disease Control (CDC), CLSI’s Global Health Partnerships (GHP) visited Tanzania, one of the first countries with which GHP partnered, in 2005. This was to be the first of many visits and a long-term partnership.

M24 is an important foundation guideline that supports CLSI’s library of antimicrobial and antifungal susceptibility testing documents.

CLSI’s GHP team will be hosting a workshop on February 9-11th at the Medlab Middle East exhibition in Dubai. Participants will learn how a laboratory can establish an internal audit program to enhance the quality of its services through continual improvement.

EP35—Assessment of Equivalence or Suitability of Specimen Types for Medical Laboratory Measurement Procedures, 1st Edition provides recommendations for assessing clinically equivalent performance for additional specimen types.